NRXS insider filings
Neuraxis, INC — 41 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-08. Screen NRXS transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 7 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings by 3 insiders — 2,533 shares, $12,260 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 1,937 shares @ $4.84 ($9,375) by Henrichs Timothy Robert, filed 2026-10-08.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Henrichs Timothy Robert — Chief Financial Officer | 1 | 1 leg · 1,937 sh · $9,375 | — | — |
| Carrico Thomas Joeseph — CRO, CCO, CPO | 2 | 1 leg · 328 sh · $1,588 | — | 4 |
| Carrico Brian Allen — Chief Executive Officer, Director | 2 | 1 leg · 268 sh · $1,297 | — | 4 |
| Miranda Adrian — CMO, SVP Science & Tech | 1 | — | — | 4 |
| Blanchard Craig Thomas — Chief Commercial Officer | 1 | — | — | — |
Recent insider filings — Neuraxis, INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-08 | 4 | Carrico Brian Allen — Chief Executive Officer, Director | Purchase (P): 268 @ $4.84 | EDGAR |
| 2026-10-08 | 4 | Carrico Thomas Joeseph — CRO, CCO, CPO | Purchase (P): 328 @ $4.84 | EDGAR |
| 2026-10-08 | 4 | Henrichs Timothy Robert — Chief Financial Officer | Purchase (P): 1,937 @ $4.84 | EDGAR |
| 2026-09-29 | 3 | Blanchard Craig Thomas — Chief Commercial Officer | Holdings only — no transactions reported | EDGAR |
| 2026-08-26 | 4 | Carrico Brian Allen — Chief Executive Officer, Director | Grant/award (A): 199,188 · Conversion (C): 320,000 (derivative) @ $6.94 · Grant/award (A): 320,000 (derivative) · Conversion (C): 320,000 (derivative) | EDGAR |
| 2026-08-26 | 4 | Miranda Adrian — CMO, SVP Science & Tech | Grant/award (A): 199,106 · Conversion (C): 337,204 (derivative) @ $6.94 · Grant/award (A): 337,204 (derivative) · Conversion (C): 337,204 (derivative) | EDGAR |
| 2026-08-26 | 4 | Carrico Thomas Joeseph — CRO, CCO, CPO | Grant/award (A): 193,678 · Conversion (C): 306,236 (derivative) @ $6.94 · Grant/award (A): 306,236 (derivative) · Conversion (C): 306,236 (derivative) | EDGAR |
| 2026-08-17 | 4 | Watkins Bradley Mitchell — Director | Grant/award (A): 26,073 @ $6.28 | EDGAR |
| 2026-08-17 | 4 | Miranda Adrian — CMO, SVP Science & Tech | Grant/award (A): 133,341 (derivative) @ $6.28 | EDGAR |
| 2026-08-17 | 4 | Henrichs Timothy Robert — Chief Financial Officer | Grant/award (A): 141,479 (derivative) @ $6.28 | EDGAR |
| 2026-08-17 | 4 | Keyser Jane Elizabeth — Director | Grant/award (A): 26,073 @ $6.28 | EDGAR |
| 2026-08-17 | 4 | Carrico Thomas Joeseph — CRO, CCO, CPO | Grant/award (A): 135,906 (derivative) @ $6.28 | EDGAR |
| 2026-08-17 | 4 | Ferge Kristin A — Director | Grant/award (A): 31,134 @ $6.28 | EDGAR |
| 2026-08-17 | 4 | Aharon Gil — Director | Grant/award (A): 2,226 · Grant/award (A): 43,930 @ $6.28 · Grant/award (A): 40,068 | EDGAR |
| 2026-08-17 | 4 | Carrico Brian Allen — Chief Executive Officer, Director | Grant/award (A): 193,329 (derivative) @ $6.28 | EDGAR |
| 2026-04-30 | 4 | Aharon Gil — Director | Grant/award (A): 12,304 · Grant/award (A): 221,917 | EDGAR |
| 2026-04-03 | 4 | Henrichs Timothy Robert — Chief Financial Officer | Purchase (P): 7,593 @ $1.96 | EDGAR |
| 2026-04-03 | 4 | Carrico Thomas Joeseph — CRO, CCO, CPO | Purchase (P): 667 @ $1.96 | EDGAR |
| 2026-04-03 | 4 | Carrico Brian Allen — Chief Executive Officer, Director | Purchase (P): 8,060 @ $1.96 | EDGAR |
| 2026-03-02 | 4 | Miranda Adrian — CMO, SVP Science & Tech | Grant/award (A): 47,569 (derivative) @ $4.63 | EDGAR |
| 2026-02-26 | 4 | Watkins Bradley Mitchell — Director | Grant/award (A): 21,598 @ $4.63 | EDGAR |
| 2026-02-26 | 4 | Keyser Jane Elizabeth — Director | Grant/award (A): 21,598 @ $4.63 | EDGAR |
| 2026-02-26 | 4 | Henrichs Timothy Robert — Chief Financial Officer | Grant/award (A): 75,231 (derivative) @ $4.63 | EDGAR |
| 2026-02-26 | 4 | Carrico Thomas Joeseph — CRO, CCO, CPO | Grant/award (A): 47,569 (derivative) @ $4.63 | EDGAR |
| 2026-02-26 | 4 | Carrico Brian Allen — Chief Executive Officer, Director | Grant/award (A): 94,173 (derivative) @ $4.63 | EDGAR |
| 2026-01-30 | 4 | Aharon Gil — Director | Grant/award (A): 21,598 @ $4.63 | EDGAR |
| 2026-01-30 | 4 | Ferge Kristin A — Director | Grant/award (A): 21,598 @ $4.63 | EDGAR |
| 2025-12-29 | 4 | Aharon Gil — Director | Purchase (P): 286,138 @ $3.52 | EDGAR |
| 2025-09-10 | 4 | Watkins Bradley Mitchell — Director | Grant/award (A): 13,157 @ $2.85 | EDGAR |
| 2025-09-10 | 4 | Miranda Adrian — CMO, SVP Science & Tech | Grant/award (A): 10,000 (derivative) @ $2.18 · Grant/award (A): 30,000 (derivative) @ $2.18 · Grant/award (A): 35,000 (derivative) @ $2.42 | EDGAR |
| 2025-09-10 | 4 | Keyser Jane Elizabeth — Director | Grant/award (A): 13,157 @ $2.85 | EDGAR |
| 2025-09-10 | 4 | Henrichs Timothy Robert — Chief Financial Officer | Grant/award (A): 8,037 (derivative) @ $2.43 · Grant/award (A): 100,000 (derivative) @ $2.43 · Grant/award (A): 66,000 (derivative) @ $2.18 · Grant/award (A): 67,980 (derivative) @ $2.42 | EDGAR |
| 2025-09-10 | 4 | Carrico Thomas Joeseph — CRO, CCO, CPO | Grant/award (A): 10,000 (derivative) @ $2.18 · Grant/award (A): 27,435 (derivative) @ $2.18 · Grant/award (A): 35,000 (derivative) @ $2.42 | EDGAR |
| 2025-09-10 | 4 | Carrico Brian Allen — Chief Executive Officer, Director | Grant/award (A): 10,000 (derivative) @ $2.18 · Grant/award (A): 90,640 (derivative) @ $2.18 · Grant/award (A): 70,019 (derivative) @ $2.42 | EDGAR |
| 2025-09-10 | 4 | Ferge Kristin A — Director | Grant/award (A): 13,157 @ $2.85 | EDGAR |
| 2025-07-03 | 4 | MASIMO CORP — 10% owner | Sale (S): 531,548 @ $2.25 · Conversion (C): 289,779 @ $0.00 · Sale (S): 289,779 @ $2.25 · Option exercise (M): 289,779 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Keyser Jane Elizabeth — Director | Grant/award (A): 11,580 @ $0 | EDGAR |
| 2024-07-02 | 4 | Watkins Bradley Mitchell — Director | Grant/award (A): 11,580 @ $0 | EDGAR |
| 2024-07-02 | 4 | Ferge Kristin A — Director | Grant/award (A): 1,183 @ $0 | EDGAR |
| 2023-08-11 | 4/A | MASIMO CORP — 10% owner | Conversion (C): 531,548 · Conversion (C): 265,774 (derivative) @ $0 · Conversion (C): 144,890 (derivative) @ $0 · Conversion (C): 289,779 (derivative) @ $0 | EDGAR |
| 2023-08-10 | 4 | MASIMO CORP — 10% owner | Conversion (C): 531,548 · Conversion (C): 265,774 (derivative) @ $0 · Conversion (C): 144,890 (derivative) @ $0 · Conversion (C): 289,779 (derivative) @ $0 | EDGAR |
Recent 8-K events — Neuraxis, INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2026-07-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-10-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-23 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-09-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NRXS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs